ING Group’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q3 | – | Sell |
-5,050
| Closed | -$402K | – | 787 |
|
2019
Q2 | $402K | Buy |
+5,050
| New | +$402K | 0.01% | 587 |
|
2018
Q3 | – | Sell |
-27,500
| Closed | -$2.31M | – | 882 |
|
2018
Q2 | $2.31M | Buy |
+27,500
| New | +$2.31M | 0.04% | 205 |
|
2017
Q3 | – | Sell |
-10,169
| Closed | -$1.23M | – | 931 |
|
2017
Q2 | $1.23M | Buy |
10,169
+7,769
| +324% | +$940K | 0.02% | 282 |
|
2017
Q1 | $271K | Sell |
2,400
-17,000
| -88% | -$1.92M | ﹤0.01% | 521 |
|
2016
Q4 | $2.12M | Buy |
+19,400
| New | +$2.12M | 0.04% | 211 |
|
2016
Q3 | – | Sell |
-5,900
| Closed | -$842K | – | 609 |
|
2016
Q2 | $842K | Sell |
5,900
-2,350
| -28% | -$335K | 0.01% | 272 |
|
2016
Q1 | $1.06M | Sell |
8,250
-250
| -3% | -$32.2K | 0.01% | 288 |
|
2015
Q4 | $1.27M | Buy |
+8,500
| New | +$1.27M | 0.01% | 475 |
|
2015
Q2 | – | Sell |
-1,000
| Closed | -$282K | – | 752 |
|
2015
Q1 | $282K | Buy |
+1,000
| New | +$282K | ﹤0.01% | 747 |
|